ScreenerHero

NBIX Neurocrine Biosciences, Inc. - Common Stock

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · neurocrine.com
143.59USD+0.29%Mkt Cap: 14.55B $P/E: 20.96

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products i…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8
SFZN
Siegfried Holding AG
$3.47BUSDP/E 17.7

Key Statistics

Company
Market Cap14.55B USD
Enterprise Value14.63B USD
Revenue (TTM)3.37B USD
Gross Profit2.81B USD
Net Income (TTM)478.60M USD
Revenue/Share33.66 USD
Last Price143.59 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)20.96
P/E (Forward)12.05
PEG0.29
EV/EBITDA16.01
EV/Revenue4.34
P/S4.31
P/B3.94
EPS (TTM)6.82
EPS (Forward)11.88
52W Range
122.1434% of range186.12
52W High186.12 USD
52W Low122.14 USD
Profitability
Gross Margin98.18%
Oper. Margin22.19%
EBITDA Margin27.07%
Profit Margin16.73%
ROE14.71%
ROA10.33%
Growth
Revenue Growth39.50%
Earnings Growth31.10%
Cash Flow & Leverage
Operating CF782.70M USD
CapEx (TTM)34.00M USD
FCF Margin18.92%
FCF Yield4.39%
Net Debt71.80M USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.13
Current Ratio1.87
Quick Ratio1.46
Book Value/Sh36.35 USD
Cash/Share3.83 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateDec 29, 1995
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)207.81 USD
Upside (mean)+44.7%
Target Range164.00 USD – 253.00 USD
164.00+44.7% to mean253.00
# Analysts29
Ownership
Shares Out.101.65M
Float100.37M
Insiders1.06%
Institutions102.82%
Short Interest
Short Ratio4.8d
Short % Float6.34%
Short % Out.4.88%
Shares Short4.96M
Short (prev mo.)4.55M
Technical
SMA 50155.65 (-7.8%)
SMA 200147.27 (-2.5%)
Beta0.38
S&P 52W Chg14.58%
Avg Vol (30d)1.29M
Avg Vol (10d)1.52M
Technical Indicators
RSI (14)40.3
MACD-5.1168
MACD Signal-5.1644
MACD Hist.+0.0476
BB Upper163.36 USD
BB Middle147.77 USD
BB Lower132.18 USD
BB Width21.10%
ATR (14)4.383 USD
Vol Ratio (20d)1.31x